# Hubei Haosun Pharmaceutical Co., Ltd. – FDA Inspection, Sep 2, 2016

Source: https://www.keypedia.com/records/fda_inspections/hubei-haosun-pharmaceutical-co-ltd/2ce1f1f8-37cd-4112-9b2b-ac1dfaca97f6
Source feed: FDA_Inspections

> FDA inspection 988662 of Hubei Haosun Pharmaceutical Co., Ltd., September 02, 2016. Classification: Voluntary Action Indicated (VAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 988662
- Company Name: Hubei Haosun Pharmaceutical Co., Ltd.
- Inspection Date: 2016-09-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1280335 - 2025-08-01](https://www.keypedia.com/records/fda_inspections/hubei-haosun-pharmaceutical-co-ltd/6156ac7f-e283-400a-a016-0393c05bf7c5)
- FDA Inspection 1047621 - 2018-03-09
- FDA Inspection 867397 - 2013-11-15
- FDA Inspection 738545 - 2011-07-16

Company: https://www.keypedia.com/companies/hubei-haosun-pharmaceutical-co-ltd/a8ee3f4d-8f6b-432f-8452-d04dc31a1eee

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c